Nanoviricides (NNVC) Return on Capital Employed [ROCE] (2011 - 2026)
Nanoviricides (NNVC) recorded Return on Capital Employed [ROCE] of -93.80% in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 24.30 percentage points from -118.10% a year earlier but down 13.47 percentage points from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides reported Return on Capital Employed [ROCE] of -101.82%, down 1.03 percentage points from FY2025.
- Annual Return on Capital Employed [ROCE] has declined for four straight fiscal years, with a five-year change of -69.11 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, Return on Capital Employed [ROCE] came in at -100.78% in FY2025 (-37.71 pp), -63.07% in FY2024 (-17.59 pp), -45.48% in FY2023 (-14.83 pp) and -30.66% in FY2022 (+2.05 pp).
- Quarterly Return on Capital Employed [ROCE] has ranged from -118.10% in fiscal Q4 2025 to -31.49% in fiscal Q1 2022 over the past five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] rose in two of the last eight quarters, with an average year-over-year change of -10.03 percentage points.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 24.30 percentage points in fiscal Q4 2026, against a drop of 47.40 percentage points in fiscal Q3 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -80.33% (Q3 2026), -92.08% (Q2 2026) and -110.96% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.86% |
| 10 | Nanoviricides | 32.44 Mn | 20.10 Mn | - | -93.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -93.80% |
| Mar 31, 2026 | -80.33% |
| Dec 31, 2025 | -92.08% |
| Sep 30, 2025 | -110.96% |
| Jun 30, 2025 | -118.10% |
| Mar 31, 2025 | -102.76% |
| Dec 31, 2024 | -90.98% |
| Sep 30, 2024 | -90.64% |
| Jun 30, 2024 | -78.96% |
| Mar 31, 2024 | -84.35% |
| Dec 31, 2023 | -72.10% |
| Sep 30, 2023 | -61.49% |
| Jun 30, 2023 | -51.98% |
| Mar 31, 2023 | -36.95% |
| Dec 31, 2022 | -33.92% |
| Sep 30, 2022 | -31.99% |
| Jun 30, 2022 | -33.94% |
| Mar 31, 2022 | -32.81% |
| Dec 31, 2021 | -31.52% |
| Sep 30, 2021 | -31.49% |
API Access
Nanoviricides Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();